Immune-checkpoint inhibitors in non-small cell lung cancer: a tool to improve patients ’ selection
We examined these factors, emerging from the results of currently available studies in non-small cell lung cancer (NSCLC), aiming to provide a useful and manageable tool which can help Oncologists in their everyday clinical practice.
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, Stefania Canova, Jessica Menis, Alfredo Addeo, Antonio Russo, Diego Luigi Cortinovis Source Type: research
More News: Cancer | Cancer & Oncology | Hematology | Laboratory Medicine | Lung Cancer | Men | Non-Small Cell Lung Cancer | Study